The Massachusetts Investors Growth Stock Fund is a mutual fund managed by Putnam Investments that invests primarily in large-cap U.S. equities with strong growth potential. It targets companies demonstrating consistent earnings expansion, new business models, and competitive advantages in their sectors.
Launched in 1937, the fund operates under a long-term growth mandate. It selects stocks based on fundamental analysis, focusing on revenue momentum, profit margins, and leadership in high-growth industries such as technology, healthcare, and consumer services. The fund's objective is capital appreciation rather than income generation, making it suitable for investors seeking wealth accumulation over 5-10 years.
As of December 2023, the fund had $2.8 billion in assets under management and maintained a net expense ratio of 0.65%. It is available through brokerage accounts, retirement plans, and direct investment platforms. The fund's benchmark is the S&P 500 Index, though it often deviates from index weightings based on manager discretion.
The fund uses a bottom-up research process. Portfolio managers analyze individual company fundamentals-revenue growth, return on equity, debt levels, and cash flow-before selecting securities. They avoid sector concentration, typically limiting exposure to any single industry to below 20%.
Holdings are reviewed quarterly. The fund rebalances when a security's market cap shifts or when a company's growth trajectory changes. For example, in Q3 2023, the fund reduced positions in several semiconductor firms after earnings missed expectations, replacing them with cloud infrastructure providers showing stronger forward guidance.
Portfolio turnover averages 35% annually, indicating moderate trading activity. This contrasts with high-turnover growth funds that trade frequently based on technical signals. The Massachusetts Investors Growth Stock Fund prioritizes long-term ownership of quality businesses over short-term market timing.
As of December 2023, the top ten holdings represented 48% of the fund's total assets. These include Apple (10.2%), Microsoft (8.7%), Amazon (6.1%), and Nvidia (5.3%). All are large-cap companies with market caps exceeding $1 trillion.
| Sector | Weight (%) | Top Holdings |
|---|---|---|
| Information Technology | 34% | Apple, Microsoft, Nvidia |
| Healthcare | 18% | UnitedHealth Group, Johnson & Johnson |
| Consumer Discretionary | 12% | Amazon, Tesla |
| Financials | 9% | Visa, Mastercard |
| Communication Services | 8% | Meta Platforms, Alphabet |
Energy and utilities each account for less than 2%. The fund excludes companies with negative operating cash flow or declining revenue trends. It also avoids firms with significant exposure to volatile commodities or regulatory risk.
Over the past decade, the Massachusetts Investors Growth Stock Fund returned an average annualized 11.4%, outperforming the S&P 500's 10.2% during the same period. Its 5-year annualized return was 12.8%, compared to the benchmark's 11.1%.
Standard deviation (a measure of volatility) was 16.3% over the last five years-slightly above the S&P 500's 14.7%. The fund's beta relative to the S&P 500 is 1.12, indicating moderate sensitivity to broad market movements.
A notable distinction: while many growth funds emphasize high-growth sectors, this fund maintains a disciplined approach to valuation. It avoids overpaying for growth. For example, in 2021, it underweighted AI-focused startups with no profits despite strong market enthusiasm, citing unsustainable burn rates.
Some investors assume the Massachusetts Investors Growth Stock Fund is a "tech-only" fund due to its heavy weighting in tech stocks. That is incorrect. While IT makes up 34% of the portfolio, the fund holds diverse exposure across healthcare, consumer, and financial sectors.
Another misconception is that the fund is highly volatile. In reality, its drawdown during the 2020 market crash was limited. During March 2020, the fund declined 18.7%, compared to the S&P 500's 20.1% drop. This reflects better downside protection due to rigorous fundamental screening.
Finally, the fund is not actively marketed as a "high-risk" vehicle. Putnam's research shows that 72% of its long-term investors held the fund for over seven years, suggesting stability and alignment with patient capital strategies.
Consider an investor who contributed $10,000 annually to the Massachusetts Investors Growth Stock Fund from 2013 to 2023. Assuming reinvested dividends and no fees, the total value grew to $278,400 by December 2023. This represents a 10.4% compound annual growth rate (CAGR).
For comparison, the same contribution to a balanced fund (60% stocks, 40% bonds) would have yielded $224,100-a difference of $54,300. The higher returns stem from the fund's focus on high-growth equities and lower expense ratio versus many actively managed funds.
When evaluating the Massachusetts Investors Growth Stock Fund, consider its historical consistency, sector diversification, and low-cost structure. It is not a speculative play but a well-researched vehicle for long-term growth.
Investors should assess whether the fund aligns with their risk tolerance, time horizon, and tax situation. The fund's capital gains distributions averaged 2.1% annually over the past five years, which may impact after-tax returns in taxable accounts.